← FDA Drug Approvals (Drugs@FDA)

LIVTENCITY

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2021-11-23

Drug application

FDA Application #

NDA215596

Application type

New Drug Application

Brand name

LIVTENCITY

Generic name

MARIBAVIR

Active ingredients

MARIBAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2021-11-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown